跳至主要内容
临床试验/EUCTR2018-003893-29-GB
EUCTR2018-003893-29-GB进行中(未招募)1 期

Randomised factorial design controlled trial comparing carbamazepine, levetiracetam or active monitoring combined with or without sleep behaviour intervention in treatment naive children with rolandic epilepsy - CASTLE TRIA

King's College London0 个研究点目标入组 330 人开始时间: 2019年10月24日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
330

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • a. Children diagnosed with RE
  • b. EEG showing focal sharp waves with normal background
  • c. Aged =5 years and <13 years at the time of randomisation
  • d. Currently untreated with antiepileptic drugs
  • e. Written informed consent received from person with parental responsibility/legal representative.
  • f. Family have a valid email address and regular internet access (for online sleep intervention)
  • g. Parent and child are to have a good understanding of the English language.
  • Parent-child dyads meeting the trial criteria and the following characteristics will be eligible for inclusion in the qualitative sub-study:
  • h. Ability of parent and child to speak conversational English
  • i. Additional consent to main trial: Consent of parent to participate and for their child to participate.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 330
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range 0
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • a. Known contraindication to any of the trial drugs
  • b. Previously treated for epilepsy with antiepileptic drugs

研究者

相似试验